ARS Pharmaceuticals
SPRY on XNAS, ARS Pharmaceuticals, Inc.
Measures activity, not value. Not investment advice.
What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
No federal contracts data for ARS Pharmaceuticals.
For context, the picture for its sector (Health Care) is below.
USAspending.gov obligations by date. All Health Care companies we match.